Effects of chronic 'binge' cocaine administration on plasma ACTH and corticosterone levels in mice deficient in DARPP-32

Neuroendocrinology

Volumn 70, Issue 3, 1999, Pages 196-199

  Zhou, Yan ^a,b   Schlussman, Stefan D ^a   Ho, Ann ^a   Spangler, Rudolph ^a   Fienberg, Allen A ^b   Greengard, Paul ^b   Kreek, Mary Jeanne ^a  

^a Box 171   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Adrenal steroids; Cocaine; Corticotropin; DARPP 32; Transgenic mice

Indexed keywords

COCAINE; CORTICOSTERONE; CORTICOTROPIN; DOPAMINE; DOPAMINE RECEPTOR; PHOSPHOPROTEIN DARPP 32;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STRESS;

EID: 0032850705     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054476     Document Type: Article

References (18)

1. Moldow RL, Fischman AJ: Cocaine-induced secretion of ACTH, beta-endorphin, and corticosterone. Peplides 1987;8:819-822.
2. Yang XM, Gorman AL, Dunn AJ, Goeders NE: Anxiogenic effects of acute and chronic cocaine administration: Neurochemical and behavioral studies. Pharmacol Biochem Behav 1992;41:643-650.
3. Mendelson JH, Sholar M, Mello NK, Teoh SK, Sholar JW: Cocaine tolerance: Behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology 1998;18: 263-271.
4. Rivier C, Lee S: Stimulatory effect of cocaine on ACTH secretion: Role of the hypothalamus. Mol Cell Neurosci 1994;5:189-195.
5. Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ: Corticotropin-releasing factor and CRF-R1 mRNAs in rat brain and pituitary during 'binge' pattern cocaine administration and chronic withdrawal. J Pharmacol Exp Ther 1996;279:351-358.
6. Rivier C, Vale W: Cocaine stimulates adrenocorticotropin secretion through acorticotropin-releasing factor-mediated mechanism. Brain Res 1987;422:403-406.
7. Borowsky B, Kuhn CM: Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation. J Pharmacol Exp Ther 1991;256:204-210.
8. Spangler R, Zhou Y, Schlussman SD, Ho A, Kreek MJ: Behavioral stereotypics induced by 'binge' cocaine administration are independent of drug-induced increases in corticosterone levels. Behav Brain Res 1997;86:201-204.
9. Walaas SI, Aswad DW, Greengard P: A dopamine- and adenosine 3′,5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 1983;301:69-73.
10. Hammings HC Jr, Greengard P: DARPP-32, a dopamine- and adenosine 3′,5′-monophosphate-regulated phosphoprotein: Regional, tissue, and phylogenetic distribution. J Neurosci 1986;6:1469-1481.
11. Ouimet CC, Miller PE, Hemmings HC Jr, Walaas SI, Greengard P: DARPP-32, a dopamineand adenosine 3′,5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated regions. J Neurosci 1984;4:111-124.
12. Schenolikar S, Nairn AC: Advances in second messenger and phosphoprotein research; in Greengard P, Robison GA (eds): Advances in Second Messenger and Phosphoprotein Research. New York. Raven Press, 1991, vol 23, pp 1-121.
13. Fienberg AA, Hiroi N, Mermelstein PG, Song WJ, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace A, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault JA, Nestler EJ, Greengard P: DARPP-32: Regulator of the efficacy of dopaminergic neurotransmission. Science 1998;281:838-842.
14. Branch AD, Unterwald EM, Lee SE, Kreek MJ: Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay. Mol Brain Res 1992;14:231-238.
15. Crawlcy JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R: Behavioral phenotypes of inbred mouse strains: Implications and recommendations for molecular studies. Psychopharmacology 1997;132:107-124.
16. Wamsley JK, Gehlert DR, Filloux FM, Dawson TM: Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain. J Chem Neuroanal 1989;2:119-132.
17. Schalling M, Dagerlind A, Goldstein M, Ehrlich M, Greengard P, Hokfelt T: Comparison of gene expression of the dopamine D-2 receptor and DARPP-32 in rat brain, pituitary and adrenal gland. Eur J Pharmacol 1990;188:277-281.
18. Schluger JH, Bodner G, Gunduz M, Ho A, Kreek MJ: Abnormal metyrapone tests during cocaine abstinence. NIDA Res Monogr 1998; 178:105.